Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Cardiology
  4. Ischemic Heart Disease/Acute Coronary Syndromes
  5. Treatment
  6. Anticoagulants

Anticoagulants

  • Angina (18)
  • Antithrombotics (394)
  • Arrhythmias (187)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (9)
  • Cholesterol (105)
  • Dyslipidemia (283)
  • Endocarditis (21)
  • Heart Disease (88)
  • Heart Failure (205)
  • Hypertension (330)
  • Hypotension (22)
  • Ischemic Heart Disease/Acute Coronary Syndromes (369)
    • Cardiovascular Markers (29)
    • Drug-Induced Ischemic Heart Disease (40)
    • Guidelines (4)
    • Prevention (69)
    • Treatment (287)
      • ACEIs (68)
      • Anticoagulants (36)
      • ARBs (63)
      • ARNIs (8)
      • Aspirin (86)
      • Beta-Blockers (79)
      • Calcium Channel Blockers (27)
      • Clopidogrel (Plavix) (53)
      • Natural Medicines/Supplements (8)
      • Nitrates (14)
      • Prasugrel (Effient) (29)
      • Statins (47)
  • Myocardial Infarction (45)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (3)
  • Resources (964)
  • Stroke (180)
1 - 15 of 36 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Managing Bleeding With Anticoagulants January 2025
Article: Help Manage and Prevent Cancer-Associated VTE August 2024
Toolbox: Optimizing Care of Patients with Peripheral Artery Disease August 2024
Article: Guide Peri-Op Management of Direct Oral Anticoagulants June 2024
Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and More
May 2024
FAQ: Combination Antithrombotic Therapy
April 2024
Chart: Heparin-Induced Thrombocytopenia March 2024
Article: Answer Questions About Antithrombotics in Stent Patients November 2023
Chart: Comparison of Oral Anticoagulants March 2023
Technician Tutorial: Dispensing Oral Blood Thinners November 2022
Article: Help Ensure Appropriate DOAC Dosing August 2022
Algorithm: How to Manage High INRs in Warfarin Patients September 2020
Guideline: 2016 AHA/ACC Guideline on Management of Lower Extremity Peripheral Artery Disease July 2019
Chart: Comparison of Oral Antiplatelets November 2017
Technician Tutorial: Injectable Anticoagulants July 2016
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved